HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Naloxegol oxalate

HCID 56959086
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1354744-91-4
Standard SMILES
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5.O=C(O)C(=O)O
InChIKey
MNYIRXLCPODKLG-VUTNLTPYSA-N
Molecular formula
C36H55NO15
Average molar mass
741.8 g/mol
Monoisotopic mass
741.35717005

Overview

See also: Naloxegol (annotation moved to).

Names & identifiers

Preferred name
Naloxegol oxalate
IUPAC
(4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic acid
English name
Naloxegol Oxalate
Molecular formula
C34H53NO11.C2H2O4
Molecular weight
741.82

Names & synonyms

Naloxegol oxalate1354744-91-4NKTR-118 oxalateNaloxegol oxalate [USAN]AZ13337019 oxalateNaloxegol (oxalate)NKTR-118-oxalateAZ-13337019 oxalate(4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic acid65I14TNM33Naloxegol oxalate (USAN)UNII-65I14TNM33
Show more names
NKTR-118NKTR 118 oxalateNaloxone oxalateAZ 13337019 oxalateNaloxegol oxalate saltNKTR-118NKTR118NKTR 118Naloxegol Oxalate NKTR-118(5alpha,6alpha)-4,5-Epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-morphinan-3,14-diol ethanedioateMorphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5α,6α)-, ethanedioate (1:1)
Movantik (TN)Moventig (TN)4,5alpha-epoxy-6alpha-((3,6,7,12,15,18,21-Heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol hydrogen ethanedioate4,5alpha-Epoxy-6alpha-[(3,6,7,12,15,18,21-heptaoxadocosyl)oxy]-17-(prop-2-enyl)morphinan-3,14-diol hydrogen ethanedioateAZ 13337019 Oxalate; Moventig; NKTR 118 Oxalate; (5a,?6a)?-4,?5-?Epoxy-?6-?(3,?6,?9,?12,?15,?18,?21-?heptaoxadocos-?1-?yloxy)?-?17-?(2-?propen-?1-?yl)?-morphinan-?3,?14-?diol EthanedioateNALOXEGOL OXALATE [MI]Naloxegol Oxalate(NKTR-118)orb1226464

Properties

Computed structural propertiesFilling in

Topological polar surface area
201 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
16
Rotatable bonds
25
Heavy atoms
52
Formal charge
0
Complexity
971

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
92 · 92-95°C
storage temp.
-20 °C · -20°C Freezer, Under inert atmosphere
solubility
Chloroform (Slightly), Methanol (Slightly)
form
Solid
color
White to Off-White
FDA UNII
65 I14TNM33 · 65I14TNM33
Symbol(GHS)
5 · GHS05,GHS08,GHS07
Signal word
Danger
Hazard statements
315 · H315-H318-H334-H317-H341-H361-H370-H335-H413
Precautionary statements
201 · P201-P202-P260-P264-P270-P272-P273-P280-P284-P302+P352-P304+P341-P305+P351+P338-P310-P308+P313-P321-P362+P364-P333+P313-P342+P311-P363-P405-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Naloxegol oxalate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

Signal word
Danger
Symbol(GHS)
GHS05,GHS08,GHS07
Hazard statements
H315-H318-H334-H317-H341-H361-H370-H335-H413
Precautionary statements
P201-P202-P260-P264-P270-P272-P273-P280-P284-P302+P352-P304+P341-P305+P351+P338-P310-P308+P313-P321-P362+P364-P333+P313-P342+P311-P363-P405-P501

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

NALOXEGOL OXALATE

Opioid Antagonists [MoA]; Opioid Antagonist [EPC]

Applications · 2 items

DescriptionNaloxegol oxalate (XXI) is a peripherally acting μ-opioid receptor antagonist that was approved in the USA and EU for the treatment of opioid-induced constipation in adults with chronic non-cancer pain. The drug, a pegylated version of naloxone, has significantly reduced central nervous system (CNS) penetration and works by inhibiting the binding of opioids in the gastrointestinal tract. Naloxegol oxalate was developed by Nektar and licensed to AstraZeneca. Although we were unable to find a single report in the primary or patent literature that describes the exact experimental procedures to prepare naloxegol oxalate, there have been reports on the preparation of closely related analogs with specific reports on improving the selectivity of the reduction step156 and the salt formation of the final drug substance.

UsesNaloxegol Oxalate is an oxalate form of Naloxegol (N284470) which is a peripherally-selective opioid antagonist.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1354744-91-4
PubChem CID
56959086
DTXSID
DTXSID50159395
ChEMBL
CHEMBL2219416
UNII
65I14TNM33